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Numerous animal studies indicate that controlled mecha-
nical ventilation (MV) induces diaphragm weakness and 
myoﬁ  ber atrophy, but no data in humans conﬁ  rm MV per 
se produces diaphragm weakness. In their recent publi-
cation, Hermans and colleagues [1] used an objective 
non  volitional technique of bilateral anterolateral mag-
netic stimulation of the phrenic nerves to measure twitch 
transdiaphragmatic pressure (TwPdi) and assessed the 
degree of diaphragm weakness in ten critically ill 
mechanically ventilated patients. Importantly, they found 
an average TwPdi value of 11.5 ± 3.9 cm water, which 
represents a 70% reduction in diaphragm strength when 
compared to normal individuals. In their analysis, the 
authors suggest that duration of MV is associated with 
decreased diaphragm force generation. Th  is interpre-
tation, however, may be misleading. Importantly, nine of 
the ten patients in their study were septic and eight out of 
ten received corticosteroids. Moreover, no information 
regarding glucose control is included. Since sepsis, 
cortico  steroid use and hyperglycemia are major risk 
factors for acquired weakness [2,3], it seems plausible 
that these conditions also contributed to the diaphragm 
weakness observed.
Whether or not diaphragm weakness results from 
sepsis, respiratory muscle unloading from MV, cortico-
steroids, hyperglycemia, or a combination of these 
factors, however, is not the most important issue raised 
by this study. Hermans and colleagues [1] should be 
congratulated because their study makes an important 
contribution by providing additional evidence that many 
critically ill patients have profound diaphragm weakness 
[4,5]. If diaphragm weakness of this magnitude is present 
in most mechanically ventilated patients, a strong argu-
ment can be made that respiratory muscle weakness is a 
major contributor to respiratory failure.
Consider this - mechanical ventilators are not artiﬁ  cial 
lungs but simply machines that substitute for the 
respiratory pump. Th   e fact is that the respiratory pump 
does not have an unlimited capacity; if it did, theo-
retically, some patients would require augmented oxygen 
delivery and/or end expiratory pressure but none would 
require MV. For patients with normal respiratory muscle 
function, respiratory failure usually occurs when the 
respiratory workload becomes too high for the normal 
pump to maintain ventilation. In principal, any reduction 
in pump function below normal should increase the 
propensity for respiratory failure to develop, with the 
level of respiratory workload required to induce respira-
tory failure directly related to the level of pump function. 
Speciﬁ  cally, the lower the pump function, the lower the 
respiratory workload required to induce respiratory 
failure. If this concept is correct, the level of respiratory 
muscle dysfunction reported by Hermans and colleagues 
should be a major contributor to respiratory failure.
Unless the patient has a known neuromuscular 
disorder, critical care physicians often overlook dia-
phragm weakness as an important factor contributing to 
respiratory failure and weaning diﬃ   culties in a signiﬁ  cant 
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tion, perhaps because conceptually this is easier to 
understand, easier to assess using chest radiographs, and, 
for the most part, the treatment options are relatively 
straightforward. On the other hand, if we recognize that 
diaphragm weakness is present, what can we do? 
Regrettably, the current approach to diaphragm weakness 
in critically ill patients is similar to the approach to 
pulmonary hypertension 30 years ago. Physicians once 
believed pulmonary hypertension was extremely rare, 
and there were no treatments. Today, we recognize that 
pulmonary hypertension is more prevalent, we have 
better tools to diagnose this problem, and we have a 
growing ensemble of pharmacological agents to treat 
patients with this disorder. To make such progress in 
dealing with the problem of respiratory muscle dysfunc-
tion in critically ill patients, we need better diagnostic 
tools, a better understanding of the pathophysiology of 
this disorder and, most importantly, we need to develop 
rational, speciﬁ   c and eﬀ   ective treatments. Once these 
goals are met, we may be able to substantially shorten the 
duration of MV in ICU patients and improve long-term 
outcomes in this growing population of patients.
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